TY - JOUR AU - Yang, Bumhee AU - Choi, Hayoung AU - Kim, Sang-Heon AU - Yoon, Ho Joo AU - Lee, Hyun PY - 2019 TI - How will nanotechnology lead to better control of asthma? JF - Annals of Translational Medicine; Vol 7, No 20 (October 31, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Asthma is a common inflammatory disease of the lungs characterized by reversible airway obstruction, bronchial hyper-responsiveness, and chronic airway inflammation (1). The most widely used therapies for asthma include inhaled corticosteroids and bronchodilators (short- or long-acting β 2 -adrenergic agonists or muscarinic antagonists). Although most patients with asthma respond well to inhaled corticosteroids, asthma control is poor in some patients who require maximal dosages (2). UR - https://atm.amegroups.org/article/view/30054